Business Description
Affymax Inc
NAICS : 325412
SIC : 2834
ISIN : US00826A1097
Description
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.65 | |||||
| 9-Day RSI | 40.77 | |||||
| 14-Day RSI | 43.54 | |||||
| 6-1 Month Momentum % | -61.9 | |||||
| 12-1 Month Momentum % | 33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -19919.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.01 | |||||
| EV-to-EBIT | 0.01 | |||||
| EV-to-EBITDA | 0.01 | |||||
| EV-to-Revenue | 0.71 | |||||
| Earnings Yield (Greenblatt) % | No Debt | |||||
| FCF Yield % | -27886.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AFFY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Affymax Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.042 | ||
| EPS (TTM) ($) | 0.06 | ||
| Beta | 4.09 | ||
| Volatility % | 299.07 | ||
| 14-Day RSI | 43.54 | ||
| 14-Day ATR ($) | 0.000078 | ||
| 20-Day SMA ($) | 0.00082 | ||
| 12-1 Month Momentum % | 33.33 | ||
| 52-Week Range ($) | 0.0006 - 0.0407 | ||
| Shares Outstanding (Mil) | 37.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Affymax Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Affymax Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Affymax Inc Frequently Asked Questions
What is Affymax Inc(AFFY)'s stock price today?
The current price of AFFY is $0.00. The 52 week high of AFFY is $0.04 and 52 week low is $0.00.
When is next earnings date of Affymax Inc(AFFY)?
The next earnings date of Affymax Inc(AFFY) is .
Does Affymax Inc(AFFY) pay dividends? If so, how much?
Affymax Inc(AFFY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers